Overview Dividends

(HRL) Hormel Foods - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4404521001

Meats, Nuts, Frozen, Canned, Snacks

Packaged Foods & Meats
Market Cap in USD: 12,570m

IPO / Inception: 1990-01-02
Return 12m vs S&P 500: -34.8%

EPS (Earnings per Share)

EPS CAGR: -8.14%
EPS Trend: -81.1%

Last SUE: 0.52
Qual. Beats: 0

Revenue

Rev. CAGR: 1.22%
Rev. Trend: -15.5%

Last SUE: -0.63
Qual. Beats: 0

Dividends

Dividend Yield	6.50%
Yield on Cost 5y	3.77%
Yield CAGR 5y	4.31%
Payout Consistency	96.7%
Payout Ratio	84.9%

Risk via 5d forecast
Volatility	23.1%
Value at Risk 5%th	36.1%
Relative Tail Risk	-5.08%

Reward TTM
Sharpe Ratio	-1.09
Alpha	-31.01
CAGR/Max DD	-0.39

Character TTM
Hurst Exponent	0.632
Beta	0.076
Beta Downside	-0.077

Drawdowns 3y
Max DD	49.51%
Mean DD	26.74%
Median DD	29.01%

Description: HRL Hormel Foods January 03, 2026

Hormel Foods Corp. (HRL) manufactures, processes, and distributes a broad portfolio of meat, nut, and other food products to retail, food-service, and international customers. The business is organized into three segments-Retail, Foodservice, and International-and offers both perishable items (e.g., bacon, refrigerated meals, guacamole) and shelf-stable goods (e.g., canned meats, nut butters, microwaveable meals). Its brands include Hormel, Spam, Skippy, and many private-label lines, sold through a mix of direct sales, brokers, and distributors.

Key operating metrics: FY2023 net sales were approximately $12.6 billion, with an adjusted operating margin of ~12%, reflecting steady pricing power despite higher commodity costs. The protein sector is driven by rising consumer demand for convenient, high-protein meals and by volatile livestock prices, which together affect gross margins. Additionally, inflationary pressure on discretionary food spending and the ongoing shift toward private-label alternatives are important macro-economic headwinds for the packaged-foods industry.

For a deeper, data-rich look at Hormel’s valuation and peer comparison, check out the ValueRay analysis.

Piotroski VR‑10 (Strict, 0-10) 4.5

Net Income (478.2m TTM) > 0 and > 6% of Revenue (6% = 726.4m TTM)

FCFTA 0.04 (>2.0%) and ΔFCFTA -3.53pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 16.73% (prev 15.50%; Δ 1.23pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.06 (>3.0%) and CFO 845.2m > Net Income 478.2m (YES >=105%, WARN >=100%)

Net Debt (2.19b) to EBITDA (1.01b) ratio: 2.17 <= 3.0 (WARN <= 3.5)

Current Ratio 2.47 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (550.5m) change vs 12m ago 0.19% (target <= -2.0% for YES)

Gross Margin 15.47% (prev 16.96%; Δ -1.49pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 90.25% (prev 88.73%; Δ 1.52pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 9.50 (EBITDA TTM 1.01b / Interest Expense TTM 78.0m) >= 6 (WARN >= 3)

Altman Z'' 4.59

(A) 0.15 = (Total Current Assets 3.41b - Total Current Liabilities 1.38b) / Total Assets 13.39b

(B) 0.56 = Retained Earnings (Balance) 7.52b / Total Assets 13.39b

(D) 1.33 = Book Value of Equity 7.28b / Total Liabilities 5.48b

Total Rating: 4.59 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 51.54

1. Piotroski 4.50pt

2. FCF Yield 3.62%

3. FCF Margin 4.41%

4. Debt/Equity 0.36

5. Debt/Ebitda 2.17

6. ROIC - WACC (= 1.41)%

7. RoE 5.97%

8. Rev. Trend -15.52%

9. EPS Trend -81.12%

What is the price of HRL shares?

As of January 08, 2026, the stock is trading at USD 22.34 with a total of 4,284,949 shares traded.
Over the past week, the price has changed by -5.74%, over one month by -6.33%, over three months by -5.77% and over the past year by -22.76%.

Is HRL a buy, sell or hold?

Hormel Foods has received a consensus analysts rating of 3.25. Therefor, it is recommend to hold HRL.

Strong Buy: 1
Buy: 1
Hold: 10
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the HRL price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	27.3	22%
Analysts Target Price	27.3	22%
ValueRay Target Price	20.2	-9.5%

HRL Fundamental Data Overview January 08, 2026

Market Cap USD = 12.57b (12.57b USD * 1.0 USD.USD)
P/E Trailing = 26.2644
P/E Forward = 15.9744
P/S = 1.0383
P/B = 1.5909
P/EG = 1.5589
Beta = 0.324
Revenue TTM = 12.11b USD
EBIT TTM = 741.7m USD
EBITDA TTM = 1.01b USD
Long Term Debt = 2.85b USD (from longTermDebt, last quarter)
Short Term Debt = 6.65m USD (from shortTermDebt, last quarter)
Debt = 2.86b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.19b USD (from netDebt column, last quarter)
Enterprise Value = 14.76b USD (12.57b + Debt 2.86b - CCE 670.7m)
Interest Coverage Ratio = 9.50 (Ebit TTM 741.7m / Interest Expense TTM 78.0m)
FCF Yield = 3.62% (FCF TTM 534.4m / Enterprise Value 14.76b)
FCF Margin = 4.41% (FCF TTM 534.4m / Revenue TTM 12.11b)
Net Margin = 3.95% (Net Income TTM 478.2m / Revenue TTM 12.11b)
Gross Margin = 15.47% ((Revenue TTM 12.11b - Cost of Revenue TTM 10.23b) / Revenue TTM)
Gross Margin QoQ = 13.37% (prev 16.07%)
Tobins Q-Ratio = 1.10 (Enterprise Value 14.76b / Total Assets 13.39b)
Interest Expense / Debt = 0.69% (Interest Expense 19.6m / Debt 2.86b)
Taxrate = -159.9% (out of range, set to none) (34.6m / -21.6m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 2.47 (Total Current Assets 3.41b / Total Current Liabilities 1.38b)
Debt / Equity = 0.36 (Debt 2.86b / totalStockholderEquity, last quarter 7.90b)
Debt / EBITDA = 2.17 (Net Debt 2.19b / EBITDA 1.01b)
Debt / FCF = 4.09 (Net Debt 2.19b / FCF TTM 534.4m)
Total Stockholder Equity = 8.01b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.57% (Net Income 478.2m / Total Assets 13.39b)
RoE = 5.97% (Net Income TTM 478.2m / Total Stockholder Equity 8.01b)
RoCE = 6.83% (EBIT 741.7m / Capital Employed (Equity 8.01b + L.T.Debt 2.85b))
RoIC = 6.54% (EBIT 741.7m / (Assets 13.39b - Curr.Liab 1.38b - Cash 670.7m))
WACC = 5.13% (E(12.57b)/V(15.43b) * Re(6.30%) + (debt cost/tax rate unavailable))
Discount Rate = 6.30% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 0.21%
[DCF Debug] Terminal Value 76.43% ; FCFE base≈724.7m ; Y1≈643.8m ; Y5≈538.9m
Fair Price DCF = 17.75 (DCF Value 9.76b / Shares Outstanding 550.1m; 5y FCF grow -13.76% → 3.0% )
EPS Correlation: -81.12 | EPS CAGR: -8.14% | SUE: 0.52 | # QB: 0
Revenue Correlation: -15.52 | Revenue CAGR: 1.22% | SUE: -0.63 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.35 | Chg30d=+0.008 | Revisions Net=+0 | Analysts=7
EPS current Year (2026-10-31): EPS=1.46 | Chg30d=+0.017 | Revisions Net=+1 | Growth EPS=+6.9% | Growth Revenue=+2.4%
EPS next Year (2027-10-31): EPS=1.56 | Chg30d=+0.024 | Revisions Net=-2 | Growth EPS=+6.3% | Growth Revenue=+2.2%

Additional Sources for HRL Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle